KALV
KalVista Pharmaceuticals, Inc. · Healthcare
Novo Holdings A/s sold $1.3M of KalVista Pharmaceuticals, Inc.
10% owner
Sold$1,273,956
$7.21Price
176,644Shares
−6%Stake
What KALV did after the filing
Prices for KALV after this filing aren't in yet.
Traded Wed, Sep 13. Filed Mon, Sep 18, 7:04 PM ET, after the close. Not investment advice.